Comparison of toxicity of selected mustard agents by percutaneous and subcutaneous routes

被引:0
|
作者
Sharma, Manoj [1 ]
Vijayaraghavan, R. [1 ]
Ganesan, K. [1 ]
机构
[1] Def Res & Dev Estab, Gwalior 474002, India
关键词
Mechlorethamine; Nitrogen mustard; Oxidative stress; Sulphur mustard; Toxicity;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Comparative toxicity of nitrogen mustards (HN-1, HN-2 and HN-3) and sulphur mustard was carried out in mice. Based on LD50, the toxicity pattern was HN-2 < HN-1 < HN-3 < sulphur mustard by percutaneous route whereas, by subcutaneous route the toxicity pattern was sulphur mustard < HN-3 < HN-2 < HN-1. Single dose of I LD50 of nitrogen mustards and sulphur mustard was administered percutaneously and various oxidative stress parameters were also evaluated. ne weight loss was more in HN-2 on day 3 and in sulphur mustard on day 7. There was a drastic fall of WBC count on day 3 in all groups with a recovery in nitrogen mustard groups on day 7. The RBC count and haemoglobin content showed a significant increase on day 7 in sulphur mustard group. The plasma enzymes (ALT, AST and ALP) showed an increase in all groups on day 3 and day 7. The hepatic GSH and GSSG contents were reduced and MDA content increased in all groups, with a further change in sulphur mustard on 7 day. Extensive DNA fragmentation was observed in all the nitrogen mustard groups compared to sulphur mustard group, on day 3. However, on the day 7 the DNA fragmentation was same in all groups. This study showed that the nitrogen mustards and sulphur mustard were extremely toxic by percutaneous route and caused oxidative stress. Sulphur mustard was more toxic by the percutaneous route and the effects were delayed and progressive.
引用
收藏
页码:822 / 830
页数:9
相关论文
共 50 条
  • [21] Estimates of percutaneous toxicity of sulfur mustard vapor suitable for use in protective equipment standards
    Dickson, Eva F. Gudgin
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2008, 71 (20): : 1382 - 1391
  • [22] COMPARISON OF VIRULENCE FOR MICE OF SALMONELLA-TYPHIMURIUM GIVEN BY INTRAPERITONEAL AND SUBCUTANEOUS ROUTES
    CRONLYDI.S
    JOURNAL OF HYGIENE, 1973, 71 (02) : 223 - 225
  • [23] APOMORPHINE IN TREATMENT OF PARKINSONS-DISEASE - COMPARISON BETWEEN SUBCUTANEOUS AND SUBLINGUAL ROUTES
    DEFFOND, D
    DURIF, F
    TOURNILHAC, M
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (01): : 101 - 103
  • [24] Comparison of nitrogen mustard, cytarabine and dacarbazine as pleural sclerosing agents in rabbits
    Marchi, E
    Vargas, FS
    Teixeira, LR
    Fagundes, DJ
    Silva, LMMF
    Carmo, AO
    Light, RW
    EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (03) : 598 - 602
  • [25] ACUTE TOXICITY OF T2 MYCOTOXIN TO THE GUINEA-PIG BY INHALATION AND SUBCUTANEOUS ROUTES
    MARRS, TC
    EDGINTON, JAG
    PRICE, PN
    UPSHALL, DG
    BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY, 1986, 67 (02): : 259 - 268
  • [26] THE INTRAVENOUS, SUBCUTANEOUS AND CUTANEOUS TOXICITY OF BIS(BETA-CHLOROETHYL) SULFIDE (MUSTARD GAS) AND OF VARIOUS DERIVATIVES
    ANSLOW, WP
    KARNOFSKY, DA
    JAGER, BV
    SMITH, HW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1948, 93 (01): : 1 - 9
  • [27] Investigation on baseline toxicity to rats based on aliphatic compounds and comparison with toxicity to fish: Effect of exposure routes on toxicity
    He, Jia
    Fu, Ling
    Wang, Yu
    Li, Jin J.
    Wang, Xiao H.
    Su, Li M.
    Sheng, Lian X.
    Zhao, Yuan H.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2014, 70 (01) : 98 - 106
  • [28] Indirect Comparison Between Subcutaneous Biologic Agents in Ankylosing Spondylitis
    Migliore, Alberto
    Bizzi, Emanuele
    Bernardi, Mauro
    Diamanti, Andrea Picchianti
    Lagana, Bruno
    Petrella, Lea
    CLINICAL DRUG INVESTIGATION, 2015, 35 (01) : 23 - 29
  • [29] Indirect Comparison Between Subcutaneous Biologic Agents in Ankylosing Spondylitis
    Alberto Migliore
    Emanuele Bizzi
    Mauro Bernardi
    Andrea Picchianti Diamanti
    Bruno Laganà
    Lea Petrella
    Clinical Drug Investigation, 2015, 35 : 23 - 29